Recruiting

NCT Number: NCT05635123

A Cohort Study of Uterine Malignancies

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cervical Cancer Endometrial Cancer Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms

Age range

20 year–75 year

Sex eligibility

Female

Study type

Observational

Primary location

Women's hospital school of medicine zhejiang university

Hangzhou, Zhejiang, 310000, China

Location status: Recruiting

Location contact

Hui Wang, PhD

CONTACT

[email protected]

057189998857

About this study

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 20-75 years;
Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
Women attending a health check-up;
Obtain informed consent and sign an informed consent form.

Exclusion criteria

Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment；
Patients with cancer other than cervical cancer or endometrial cancer;
Women who have received hysterectomy or pelvic radiation therapy previously.

Treatment and study plan

No intervention

Other

This is a prospective observational study with no intervention.

Primary outcomes

progression free survival (PFS)

Time frame: 60 months

progression free survival for patients with cervical cancer or endometrial cancer

Study contacts

Contact information is provided by the study sponsor or research team.

Hui Wang, PhD

CONTACT

[email protected]

0571-89998857

Xiao Li, PhD

CONTACT

[email protected]

13958160137

Sponsors and collaborators

Lead sponsor

Women's Hospital School Of Medicine Zhejiang University

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2030
First posted: Dec 2, 2022
Registry last updated: Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting